Position in GANX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,730
-$4,693 QoQ
Shares Held
3,808
-40.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 49 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GROUP ONE TRADING LLC holds $113,693,049 across 200 Biotechnology names. GANX ranks #135 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
203,915 | $14,280,167 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
261,443 | $10,198,891 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
272,609 | $6,564,424 | |
| 4 | ABSI |
Absci Corp
|
524,747 | $6,081,817 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
151,994 | $5,640,497 | |
| 6 | NKTR |
Nektar Therapeutics
|
70,371 | $4,912,599 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
85,040 | $4,638,081 | |
| 8 | ABVX |
Abivax S.A.
|
29,767 | $3,966,750 |
All Filings in GANX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,730 | 3,808 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,423 | 6,404 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $174,391 | 54,159 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $29,691 | 16,775 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $11,521 | 6,401 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $2,493 | 1,401 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,473 | 7,401 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,543 | 2,001 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $12,854 | 3,937 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,353 | 1,937 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,794 | 847 | Shares | Sole | 2023-08-09 | |
| No filing history on record for this holder in this stock. | ||||||